Most Favored Nation Policy

The Centers for Medicare & Medicaid Services (CMS) has unveiled substantial price reductions for 15 high-cost Medicare drugs under the Inflation Reduction Act (IRA), promising significant savings for patients and taxpayers. These changes, effective from January 2027, have sparked questions…